Sapovirus II

If you or your child has diarrhea and vomiting, finding sapovirus in stool can help explain the illness. Bacterial stool cultures don't detect this virus, though some molecular gastrointestinal panels already include it. A positive result needs to be read alongside your symptoms because sapovirus RNA can also appear in stool without illness or after recovery.

What This Test Detects

Sapovirus genogroup II, usually shortened to GII, is one genetic group within the sapovirus family of related viruses. Sapovirus and norovirus belong to the same broader virus family and can cause similar stomach illnesses. Human sapovirus infections mainly involve genogroups GI, GII, GIV, and GV.

This stool test targets GII using qPCR. Sapovirus carries its genetic instructions in RNA, so PCR detection requires an initial step that copies RNA into DNA. The assay then makes repeated copies of a selected genetic sequence and tracks the signal. Detecting that sequence establishes that viral genetic material is present in the sample; it doesn't establish that every detected particle is infectious.

Many published studies and clinical panels detect several sapovirus genogroups together. This test reports GII separately. Unless a finding below names GII, it concerns sapovirus across multiple genogroups. Those studies help explain the infection, but they don't directly validate the quantitative result from this particular assay.

What the Reported Number Means

Molecular detection of sapovirus in stool is an established diagnostic approach, including on FDA-cleared panels. Those clearances apply to the specific panels evaluated. They don't establish the performance of every GII-specific test or the clinical meaning of its reported amount.

This test lists its unit as CFU/g stool. CFU conventionally refers to colonies grown in culture. Sapovirus does not form bacterial colonies, and qPCR detects genetic material. The laboratory's calibration is therefore needed to explain what this number represents.

Research assays commonly report RNA copies or the number of copying cycles needed to detect a signal. Those results cannot be converted into this test's CFU/g value without a validated relationship. The cited studies do not establish a CFU/g target that diagnoses symptomatic infection, predicts severity, or proves that you are no longer contagious.

Stomach Illness in Young Children

Young children have the greatest burden of sapovirus illness. A birth cohort following 1,715 children across eight countries found frequent infections during the first two years of life, including infections without diarrhea. The study measured sapovirus across genogroups.

GII accounts for a substantial share in some settings. In a Finnish hospital study, it represented 52% of sapovirus detections among children with gastroenteritis, mostly GII.1. That percentage describes the strains found in that study, not the chance that your child's illness is caused by GII. The distribution of strains varies by place and time.

Symptoms commonly include watery diarrhea, vomiting, nausea, and abdominal cramps; fever can occur. These symptoms overlap with other infections. The genogroup alone does not reliably predict how ill you or your child will become.

Adults and Outbreaks

Adults get sapovirus too, and outbreaks occur in childcare centers, hospitals, and care homes. In an Alberta study, most sapovirus outbreaks occurred in hospitals, long-term care facilities, and senior lodges. Several genogroups were involved, so this was evidence about sapovirus broadly.

A year of testing Spanish outpatients of all ages with gastroenteritis found sapovirus in about 16%, making it the second most frequently detected virus after norovirus. GI was the most common genogroup, followed by GII. A German inpatient study also found GII.1 and GII.3 among the leading strains. These local detection rates should not be treated as the probability that sapovirus explains any particular episode of diarrhea.

When Infection Persists

Sapovirus can persist when the immune system is suppressed. In a study of adults receiving cancer care, it was detected in 0.45% of those tested with a gastrointestinal pathogen panel. A subset of transplant recipients had prolonged detection, with a median of 97 days and a longest observed duration of 495 days. Those durations describe the selected subgroup with prolonged detection, not the usual course in everyone receiving transplant or cancer treatment. The panel detected sapovirus across genogroups.

GII-specific chronic infections have also been documented. A small series included GI.2, GII.1, and GII.3 infections in immunocompromised people, with shedding lasting up to 119 days across the series. Persistent diarrhea in this setting can have several causes, so a viral finding may explain part of the illness without explaining all of it.

Severe Illness

Most otherwise healthy people recover within days, but fluid loss can cause dehydration. Young children, older adults, and people with chronic illness or weakened immunity can be more vulnerable to complications.

Sapovirus has been detected in fatal diarrheal illnesses, though detection alone cannot establish the cause of death. In a South African study of children hospitalized with diarrhea, two children who died had sapovirus as the only detected pathogen. Other children had multiple infections. These findings concern sapovirus across genogroups and do not establish a GII-specific fatality risk.

A Positive Result Without Symptoms

Sapovirus RNA can remain detectable after symptoms stop, and some infections never cause symptoms. In a Peruvian birth cohort, the median shedding duration was 18.5 days across symptomatic and asymptomatic infections combined. Some infections remained detectable for more than a month. The study did not find a clear difference in shedding duration between infections with and without diarrhea.

Studies comparing people with and without gastroenteritis help show why a positive result needs context. These studies used their own molecular assays and counted sapovirus across genogroups.

The amount of RNA can add context, but the values overlap between people with and without symptoms. A separate primary-care case-control study found that its PCR signal could not reliably distinguish symptomatic sapovirus infection from asymptomatic detection. A positive during a compatible illness supports sapovirus as a possible cause; the amount alone cannot settle that question.

Other organisms can appear in the same sample. In one Spanish study, another pathogen was detected in 25% of sapovirus-positive samples. That proportion varies across populations and testing panels. Finding sapovirus does not exclude a bacterial infection, another virus, or a noninfectious cause of diarrhea.

Repeat Infections and Partial Immunity

Previous infection appears to provide partial protection. In the eight-country birth cohort, a prior sapovirus infection was associated with a 22% lower rate of subsequent infection and a 24% lower rate of sapovirus-associated diarrhea. These were observational findings across genogroups.

An Australian cohort of 158 children found a similar association with fewer subsequent infections. That study used weekly stool swabs and did not distinguish genogroups. Studies that identified individual strains found repeat infections commonly involved a different genotype, suggesting that some protection is strain-specific. A previous GII infection does not guarantee protection against another sapovirus infection.

When Results Can Be Misleading

• Detection after recovery: RNA can remain in stool after the illness has ended. A positive result does not by itself show ongoing symptomatic disease.
• Detection without illness: some infections cause no symptoms. A positive result in someone who feels well does not establish a condition that needs treatment.
• More than one cause: co-detected pathogens and noninfectious conditions can explain some or all of your symptoms.
• False positives: a 2026 evaluation of the BioFire FilmArray gastrointestinal panel found that 18.8% of its sapovirus-positive results were not confirmed by reference methods. That was a different, qualitative assay covering multiple genogroups in a selected study population; the percentage is not the false-positive probability for this GII test.
• False negatives: low amounts of RNA, problems with collection or storage, and substances in stool that interfere with PCR can prevent detection. Internal controls help identify interference, but no assay detects every infection.
• Limited coverage: a GII-only negative result does not exclude GI, GIV, or GV sapovirus, or other causes of gastroenteritis.
• Uncertain quantitative interpretation: sample processing and assay calibration affect the reported amount. A change in CFU/g has no established meaning for severity or contagiousness without validation specific to this assay.